Zhejiang Kadi Pharmaceutical Co., Ltd. is a state-level high-tech enterprise integrating R & D, manufacture and sales, with fixed assets of more than 250 million RMB and annual production value of over 300 million RMB. We now have 60 R & D personnel, 2 of whom are PhDs, 28 are masters or bachelors, and 19 are technicians. Our second-phase diazadicyclomine project has started construction, which, with planned investment of 100 million RMB, are to be put into service in 2011, with production capacity of 100 tons, and additional sales revenue of 300 million RMB.
Basing on such policy of Equality and Mutual Benefit and upholding such principle of Customer First, Credit First, Kadi is working to provide excellent service for our customers all over the world. We are looking forward to cooperating with you for mutual development.